Matthew Sykes
Stock Analyst at Goldman Sachs
(4.14)
# 753
Out of 4,479 analysts
148
Total ratings
58.42%
Success rate
9.17%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Initiates: Neutral | $28 | $23.86 | +17.35% | 1 | Jun 6, 2024 | |
| IQV IQVIA Holdings | Initiates: Buy | $270 | $208.49 | +29.50% | 1 | Jun 6, 2024 | |
| ICLR ICON PLC | Initiates: Buy | $370 | $316.51 | +16.90% | 1 | Jun 6, 2024 | |
| CRL Charles River Laboratories International | Initiates: Buy | $290 | $203.24 | +42.69% | 1 | Jun 6, 2024 | |
| OMIC Singular Genomics Systems | Maintains: Neutral | $26 → $23 | $8.52 | +164.08% | 10 | May 15, 2024 | |
| CDNA CareDx | Maintains: Buy | $10 → $14 | $15.38 | -8.97% | 6 | May 13, 2024 | |
| TXG 10x Genomics | Maintains: Sell | $30 → $26 | $18.59 | +39.86% | 4 | May 1, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $7 → $2.5 | $1.20 | +108.33% | 3 | Apr 19, 2024 | |
| VCYT Veracyte | Maintains: Buy | $32 → $28 | $21.33 | +31.27% | 3 | Apr 15, 2024 | |
| NTRA Natera | Maintains: Buy | $90 → $100 | $107.81 | -7.24% | 11 | Apr 15, 2024 | |
| GH Guardant Health | Maintains: Buy | $32 → $28 | $28.26 | -0.92% | 9 | Apr 15, 2024 | |
| WGS GeneDx Holdings | Maintains: Neutral | $6 → $11 | $28.69 | -61.66% | 6 | Apr 15, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $550 → $640 | $541.72 | +18.14% | 3 | Apr 10, 2024 | |
| BRKR Bruker | Maintains: Sell | $66 → $74 | $62.33 | +18.72% | 2 | Apr 10, 2024 | |
| CTKB Cytek Biosciences | Maintains: Buy | $9 → $10 | $5.61 | +78.25% | 8 | Feb 29, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $17 → $19 | $13.93 | +36.40% | 5 | Feb 22, 2024 | |
| MYGN Myriad Genetics | Maintains: Buy | $28 → $31 | $23.97 | +29.33% | 9 | Jan 30, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $1.25 → $1.1 | $0.32 | +240.35% | 5 | Jan 23, 2024 | |
| TWST Twist Bioscience | Maintains: Buy | $25 → $45 | $48.93 | -8.03% | 8 | Jan 18, 2024 | |
| AVTR Avantor | Maintains: Buy | $23 → $26 | $20.77 | +25.18% | 4 | Dec 7, 2023 | |
| A Agilent Technologies | Maintains: Buy | $128 → $145 | $127.40 | +13.81% | 4 | Dec 7, 2023 | |
| DHR Danaher | Downgrades: Neutral | n/a | $244.51 | - | 3 | Dec 7, 2023 | |
| QGEN Qiagen | Upgrades: Buy | n/a | $40.23 | - | 4 | Dec 7, 2023 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,185 → $1,030 | $1,366.84 | -24.64% | 4 | Nov 13, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $7 | $6.94 | +0.86% | 6 | Nov 9, 2023 | |
| EXAS Exact Sciences | Maintains: Buy | $100 → $90 | $42.43 | +112.11% | 5 | Nov 3, 2023 | |
| RVTY Revvity | Maintains: Buy | $120 → $105 | $103.00 | +1.94% | 1 | Oct 31, 2023 | |
| QTRX Quanterix | Maintains: Buy | $30 → $34 | $12.68 | +168.14% | 12 | Sep 28, 2023 | |
| OLK Olink Holding AB (publ) | Maintains: Neutral | $16 → $18 | $25.55 | -29.55% | 5 | Feb 23, 2023 | |
| NAUT Nautilus Biotechnology | Maintains: Neutral | $4 → $2 | $2.27 | -11.89% | 4 | Aug 3, 2022 |
Fortrea Holdings
Jun 6, 2024
Initiates: Neutral
Price Target: $28
Current: $23.86
Upside: +17.35%
IQVIA Holdings
Jun 6, 2024
Initiates: Buy
Price Target: $270
Current: $208.49
Upside: +29.50%
ICON PLC
Jun 6, 2024
Initiates: Buy
Price Target: $370
Current: $316.51
Upside: +16.90%
Charles River Laboratories International
Jun 6, 2024
Initiates: Buy
Price Target: $290
Current: $203.24
Upside: +42.69%
Singular Genomics Systems
May 15, 2024
Maintains: Neutral
Price Target: $26 → $23
Current: $8.52
Upside: +164.08%
CareDx
May 13, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $15.38
Upside: -8.97%
10x Genomics
May 1, 2024
Maintains: Sell
Price Target: $30 → $26
Current: $18.59
Upside: +39.86%
Pacific Biosciences of California
Apr 19, 2024
Maintains: Neutral
Price Target: $7 → $2.5
Current: $1.20
Upside: +108.33%
Veracyte
Apr 15, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $21.33
Upside: +31.27%
Natera
Apr 15, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $107.81
Upside: -7.24%
Guardant Health
Apr 15, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $28.26
Upside: -0.92%
GeneDx Holdings
Apr 15, 2024
Maintains: Neutral
Price Target: $6 → $11
Current: $28.69
Upside: -61.66%
Thermo Fisher
Apr 10, 2024
Maintains: Buy
Price Target: $550 → $640
Current: $541.72
Upside: +18.14%
Bruker
Apr 10, 2024
Maintains: Sell
Price Target: $66 → $74
Current: $62.33
Upside: +18.72%
Cytek Biosciences
Feb 29, 2024
Maintains: Buy
Price Target: $9 → $10
Current: $5.61
Upside: +78.25%
NeoGenomics
Feb 22, 2024
Maintains: Buy
Price Target: $17 → $19
Current: $13.93
Upside: +36.40%
Myriad Genetics
Jan 30, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $23.97
Upside: +29.33%
Ginkgo Bioworks Holdings
Jan 23, 2024
Maintains: Sell
Price Target: $1.25 → $1.1
Current: $0.32
Upside: +240.35%
Twist Bioscience
Jan 18, 2024
Maintains: Buy
Price Target: $25 → $45
Current: $48.93
Upside: -8.03%
Avantor
Dec 7, 2023
Maintains: Buy
Price Target: $23 → $26
Current: $20.77
Upside: +25.18%
Agilent Technologies
Dec 7, 2023
Maintains: Buy
Price Target: $128 → $145
Current: $127.40
Upside: +13.81%
Danaher
Dec 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $244.51
Upside: -
Qiagen
Dec 7, 2023
Upgrades: Buy
Price Target: n/a
Current: $40.23
Upside: -
Mettler-Toledo International
Nov 13, 2023
Maintains: Neutral
Price Target: $1,185 → $1,030
Current: $1,366.84
Upside: -24.64%
Maravai LifeSciences Holdings
Nov 9, 2023
Maintains: Neutral
Price Target: $8 → $7
Current: $6.94
Upside: +0.86%
Exact Sciences
Nov 3, 2023
Maintains: Buy
Price Target: $100 → $90
Current: $42.43
Upside: +112.11%
Revvity
Oct 31, 2023
Maintains: Buy
Price Target: $120 → $105
Current: $103.00
Upside: +1.94%
Quanterix
Sep 28, 2023
Maintains: Buy
Price Target: $30 → $34
Current: $12.68
Upside: +168.14%
Olink Holding AB (publ)
Feb 23, 2023
Maintains: Neutral
Price Target: $16 → $18
Current: $25.55
Upside: -29.55%
Nautilus Biotechnology
Aug 3, 2022
Maintains: Neutral
Price Target: $4 → $2
Current: $2.27
Upside: -11.89%